Brazil Finalizes Agreement With Abbott Over Kaletra Pricing

Drug Industry Daily
A A

Brazil has reached a formal agreement with Abbott that nearly halves the price the government pays for the drugmaker’s AIDS drug Kaletra.

To View This Article:

Login

Subscribe To Drug Industry Daily